In the article cited above, TG was incorrectly introduced as transforming secretory granules in the main text. The correct term is thapsigargin. The editors apologize for the error. The online version of the article (https://doi.org/10.2337/db24-0720) has been up-dated to correct the error.
Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived β-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273-1288 / Torchio, S.; Siracusano, G.; Cuozzo, F.; Zamarian, V.; Pellegrini, S.; Manenti, F.; Bonfanti, R.; Frontino, G.; Sordi, V.; Chimienti, R.; Piemonti, L.. - In: DIABETES. - ISSN 1939-327X. - 74:10(2025), pp. 1885-1885. [10.2337/db25-er10a]
Erratum. Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived β-Cells Harboring a Partially Functional WFS1 Variant. Diabetes 2025;74:1273-1288
Torchio S.Primo
;Zamarian V.;Bonfanti R.;Piemonti L.Ultimo
2025-01-01
Abstract
In the article cited above, TG was incorrectly introduced as transforming secretory granules in the main text. The correct term is thapsigargin. The editors apologize for the error. The online version of the article (https://doi.org/10.2337/db24-0720) has been up-dated to correct the error.| File | Dimensione | Formato | |
|---|---|---|---|
|
db25er10a.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Licenza OA dell'editore
Dimensione
113.88 kB
Formato
Adobe PDF
|
113.88 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
